BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10542281)

  • 21. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.
    Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E
    J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan.
    Lee ER; Lamplugh L; Davoli MA; Beauchemin A; Chan K; Mort JS; Leblond CP
    Dev Dyn; 2001 Sep; 222(1):52-70. PubMed ID: 11507769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay.
    Buttle DJ; Fowles A; Ilic MZ; Handley CJ
    Mol Pathol; 1997 Jun; 50(3):153-9. PubMed ID: 9292151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.
    Fosang AJ; Last K; Neame PJ; Murphy G; Knäuper V; Tschesche H; Hughes CE; Caterson B; Hardingham TE
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):347-51. PubMed ID: 7998967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
    Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
    Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
    Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
    Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.
    Sandy JD; Gamett D; Thompson V; Verscharen C
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):59-66. PubMed ID: 9742213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.
    Sandy JD; Thompson V; Doege K; Verscharen C
    Biochem J; 2000 Oct; 351(Pt 1):161-6. PubMed ID: 10998358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
    Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
    Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cleavage of biglycan by aggrecanases.
    Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan.
    Fosang AJ; Last K; Stanton H; Golub SB; Little CB; Brown L; Jackson DC
    Methods Mol Biol; 2010; 622():312-47. PubMed ID: 20135291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.
    Singer II; Scott S; Kawka DW; Bayne EK; Weidner JR; Williams HR; Mumford RA; Lark MW; McDonnell J; Christen AJ; Moore VL; Mudgett JS; Visco DM
    Osteoarthritis Cartilage; 1997 Nov; 5(6):407-18. PubMed ID: 9536289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
    Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
    Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
    Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.